Journal of International Psychiatry

[Abstract] Objective To investigate the current status of anxiety and depression in migraine patients and its impact on clinical symptoms. Methods The subjects of this study were 93 migraine patients from February 2021 to November 2022 at the First Peoples Hospital of Ichun City. The anxiety/depression self-rating scale (SAS)/(SDS) was used to assess anxiety and depression. Those with combined anxiety or depressive mood were set as anxiety-depression group, and the rest were set as control group. The medical records of patients in the two groups were compared. The visual analogue score of headache (VAS) and the Headache Impact Measurement-6 (HIT-6) were assessed, and the relationship between SAS and SDS scores and clinical symptom scores was analyzed. Results Among 93 patients, 9 cases were combined with anxiety, 12 cases were combined with depression, and 30 cases of anxiety-depression coexisted. The differences in age, education, and frequency of headache attacks between the anxious-depressed group and the control group were statistically significant (P<0.05), and the differences in gender and place of residence between the two groups were not statistically significant (P>0.05). VAS scores and HIT-6 scores were significantly higher in the anxious-depressed group than in the control group (P<0.05). SAS scores and SDS scores were positively correlated with VAS scores and HIT-6 scores in the anxious-depressed group (P<0.05). Conclusion Anxiety and depression are more common in migraineurs, are more often co-occurring, and may exacerbate headache symptoms and the impact of headache symptoms on life.

Key words Migraine; Anxiety; Depression; Clinical Symptoms